Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Dr Ray O’Connor takes a look at recent clinical articles on the importance of promoting vaccines for Measles, HIV, Gonorrhoea ...
Alastair Crooke, a former British ambassador, stated in a recent interview in reference to European and American political ...
“We are in the midst of a rupture, not a transition. Over the past two decades a series of crises in finance, health, energy, ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...
The “enormous revelation” that drugs can be used to prevent catching HIV has benefitted millions and helped slash ...
This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...
One Application Seeks European Commission Authorization; Other Application Would Facilitate Availability in Low- and Lower-Middle-Income Countries - - Both Applications Will Be Assessed in Parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results